Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled…
- Recall date
- December 6, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0183-2023
- FDA classification
- Class I
- Brand / firm
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5
Get recall alerts
Free email alert whenever Glaxosmithkline Consumer Healthcare Holdings DBA Haleon has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Glaxosmithkline Consumer Healthcare Holdings DBA Haleon